dual c-Met/HDAC inhibitors (Shenyang Pharmaceutical University)

N/A

Report date: 2025/03/19 09:01:41
NME

Base Information

Drug Namedual c-Met/HDAC inhibitors (Shenyang Pharmaceutical University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone deacetylase 1 inhibitorsHepatocyte growth factor receptor inhibitors
TargetsHistone deacetylase 1Hepatocyte growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShenyang Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesShenyang Pharmaceutical University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A